Dr. C Michael Gibson

Dr. C Michael Gibson, CEO of Bain and Profuse Research Institutes and a Harvard Medical School professor, joins the discussion on medical statistics and AI in clinical trials. He and Dr. Nero dive into the evolution of statistical methods, contrasting traditional models with emerging techniques like win ratios. They explore the critical role of high-quality data in medical decisions and the challenges of evaluating treatments for atrial fibrillation. Their conversation highlights the importance of addressing biases in clinical trials to improve patient outcomes.